Abstract

Background. Much work has been done to evaluate the outcome of integrative inpatient treatment but scarcely the costs. This paper evaluates the costs for inpatient treatment in three anthroposophic hospitals (AHs). Material and Methods. Cost and performance data from a total of 23,180 cases were analyzed and compared to national reference data. Subgroup analysis was performed between the cases with and without anthroposophic medical complex (AMC) treatment. Results. Costs and length of stay in the cases without AMC displayed no relevant differences compared to the national reference data. In contrast the inlier cases with AMC caused an average of € 1,394 more costs. However costs per diem were not higher than those in the national reference data. Hence, the delivery of AMC was associated with a prolonged length of stay. 46.6% of the cases with AMC were high outliers. Only 10.6% of the inlier cases with AMC were discharged before reaching the mean length of stay of each DRG. Discussion. Treatment in an AH is not generally associated with an increased use of resources. However, the provision of AMC leads to a prolonged length of stay and cannot be adequately reimbursed by the current G-DRG system. Due to the heterogeneity of the patient population, an additional payment should be negotiated individually.

Highlights

  • Integrative medicine according the US National Center for Complementary and Alternative Medicine “combines treatments from conventional medicine and complementary medicine (CAM) for which there is some high-quality evidence of safety and effectiveness” [1]

  • The spread ranges over 308 different German refined diagnosis-related groups (G-DRGs) corresponding to 26% of all inpatient G-DRGs at a level of 1,189 in the 2011 version of the G-DRG system

  • Much work has been spent to evaluate the outcome of integrative in-patient treatment [13, 14], but only some articles deal with the costs of such strategies [15, 16]

Read more

Summary

Introduction

Integrative medicine according the US National Center for Complementary and Alternative Medicine “combines treatments from conventional medicine and complementary medicine (CAM) for which there is some high-quality evidence of safety and effectiveness” [1]. AM has developed to become one of the main representatives of integrative medicine in Germany and is currently practised in over 60 countries [3]. It is explicitly designated and mentioned in the German Drug Law as a “Special Therapeutic System” alongside herbal medicine and homeopathy [4]. Cost and performance data from a total of 23,180 cases were analyzed and compared to national reference data. Subgroup analysis was performed between the cases with and without anthroposophic medical complex (AMC) treatment. Costs and length of stay in the cases without AMC displayed no relevant differences compared to the national reference data. 10.6% of the inlier cases with AMC were discharged before reaching the mean length of stay of each DRG. Due to the heterogeneity of the patient population, an additional payment should be negotiated individually

Methods
Results
Conclusion
Full Text
Published version (Free)

Talk to us

Join us for a 30 min session where you can share your feedback and ask us any queries you have

Schedule a call